Audentes Therapeutics' IPO

Audentes Therapeutics raised a round of funding on July 20, 2016. Investors include Public.

Audentes is a biotechnology company committed to the development and commercialization of treatments for people with serious, rare diseases through the application of AAV gene therapy technology. The …

Articles about Audentes Therapeutics' IPO: